Soleno (SLNO): Rega marang dodolan

Logo korporat perusahaan Soleno (SLNO)

Soleno Therapeutics (SLNO) is vying for leadership in the rare metabolic pathology segment, where orphan drug status promises a long-term monopoly. The price-to-sales multiple allows for a comparison of market demand against actual sales, with the 9.60 mark indicating the current valuation level. A strategy focused on Prader-Willi syndrome minimizes risks, while management support during the asset commercialization period confirms investor confidence.

Soleno Therapeutics, Inc. - Multiplikator P/S SLNO (periode 08.08.2025 - 30.05.2026)

Rincian metrik lan analitis perusahaan soleno.life (SLNO)

- rega saiki lan proyeksi nilai saham:
Analisis fundamental perusahaan:SLNO, Soleno Therapeutics Inc
Barang utama Soleno Therapeutics

By utilizing an asset-light model with outsourced drug manufacturing, Soleno Therapeutics (SLNO) minimizes capital expenditures by shifting operational risks to contract partners. An analysis of the price-to-sales ratio allows for an assessment of the market value of every dollar of sales, identifying whether the asset is overheated or if the business potential is undervalued during the intervals between financial reports to establish a long-term investment consensus.

Pesaing Soleno Therapeutics

Rasio rega marang pendapatan ASND (Ascendis Pharma AS)|Rasio rega marang pendapatan madrigalpharma.com MDGL|Corcept Therapeutics Corp (CORT) - Rega marang dodolan|RYTM - Rasio rega marang pendapatan|AKRO: Rasio rega marang pendapatan|MTSR: Multiplikator P/S|MLTX - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Crinetics Corp|NewAmsterdam Pharma Corp (NAMS) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan amicusrx.com (FOLD)|Kapitalisasi marang pendapatan 89bio.com ETNB|Multiplikator P/S AGIO (agios.com)|Koefisien rega marang pendapatan Structure Pharma (GPCR)|MiMedx Corp - Multiplikator P/S|Rega marang dodolan Rezolute, Inc.|LXRX (Lexicon Pharmaceuticals, Inc.) - Kapitalisasi marang pendapatan|MBX Biosciences Inc - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Altimmune Inc|Rasio kapitalisasi marang pendapatan AARD (Aardvark Therapeutics Corp)|Rasio rega marang pendapatan Sagimet Biosciences Inc (SGMT)|BioAge Labs Inc. (BIOA) - Multiplikator rega marang pendapatan|Multiplikator P/S BMEA (Biomea Fusion Corp)|quincetx.com (QNCX) - Rega marang dodolan|GUTS - Rasio rega marang pendapatan|Rega marang dodolan vTv Therapeutics|ATPC (agapeatpgroup.com) - Kapitalisasi marang pendapatan|Rasio kapitalisasi marang pendapatan PLUR|Kapitalisasi marang pendapatan SYBX|LPCN: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S MTNB|SPRB - Rega marang dodolan|Multiplikator P/S GLTO (Galecto Corporation)|Rasio kapitalisasi pasar marang pendapatan CTCX|Lumos Therapeutics - Multiplikator P/S|ONVO: Rasio rega marang pendapatan|Radius Recycling (RDUS) - Rasio rega marang pendapatan